Anthony J Furlan
Affiliation: University Hospitals Case Medical Center
- Challenges in acute ischemic stroke clinical trialsAnthony J Furlan
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA
Curr Cardiol Rep 14:761-6. 2012..The 7 STAIR conferences have been convened to address these and other challenges to acute ischemic stroke trial design and completion...
- Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due toAnthony J Furlan
Department of Neurology, Neurological Institute Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
Stroke 41:2872-83. 2010....
- Closure or medical therapy for cryptogenic stroke with patent foramen ovaleAnthony J Furlan
Department of Neurology, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
N Engl J Med 366:991-9. 2012..Closure with a percutaneous device is often recommended in such patients, but it is not known whether this intervention reduces the risk of recurrent stroke...
- Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysisAlex Abou-Chebl
Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Stroke 36:2286-8. 2005..Multimodal rescue therapy combining mechanical disruption and platelet GPIIb/IIIa receptor antagonists may improve recanalization...
- Utilization of intravenous tissue plasminogen activator for acute ischemic strokeIrene L Katzan
Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Arch Neurol 61:346-50. 2004..Intravenous tissue plasminogen activator (tPA) is the only approved therapy for acute ischemic stroke, although only 2% of patients with stroke receive intravenous tPA nationally...
- Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypassMichael E Kelly
Division of Cerebrovascular and Endovascular Neurosurgery, Department of Neurosurgery, Cleveland Clinic, S80, Cleveland, OH 44195, USA
Stroke 39:1770-3. 2008..We describe a technique in which a reconstrainable stent was used to provide a temporary endovascular bypass to achieve MCA recanalization without permanent stent implantation...
- Quality improvement for stroke management at the Cleveland Clinic Health SystemEric D Hixson
Measurement Services, The Quality Institute, Cleveland Clinic Health System, Cleveland, USA
Jt Comm J Qual Patient Saf 31:447-54. 2005..Improvement activities included professional education, public awareness, process improvement, focused data collection with routine feedback, protocol refinement, and coordination of clinical personnel within and between hospitals...
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onsetAnthony J Furlan
Department of Neurology, The Cleveland Clinic, Cleveland, OH 44195, USA
Stroke 37:1227-31. 2006..This study evaluated safety and efficacy of intravenous (IV) desmoteplase in patients with perfusion/diffusion mismatch on MRI 3 to 9 hours after onset of acute ischemic stroke...
- Mechanical thrombectomy for acute stroke with the alligator retrieval deviceMuhammad S Hussain
Section of Cerebrovascular and Endovascular Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
Stroke 40:3784-8. 2009..The Alligator retrieval device, developed for endovascular foreign body retrieval, may also be useful for thrombus removal...
- Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland updateIrene L Katzan
Department of Neurology, Cleveland Clinic Foundation, 9500 Euclid Ave, S91, Cleveland, Ohio 44195, USA
Stroke 34:799-800. 2003..We now report updated results of intravenous tPA use in the Cleveland Clinic Health System (CCHS)...
- Patent foramen ovale and recurrent stroke: closure is the best option: yesAnthony J Furlan
Department of Neurology, Cleveland Clinic, Cerebrovascular Center, Cleveland, Ohio, 44195 5001, USA
Stroke 35:803-4. 2004
- The impact of Accreditation Council for Graduate Medical Education duty hours, the July phenomenon, and hospital teaching status on stroke outcomesAmer Alshekhlee
Neurological Institute, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106 5040, USA
J Stroke Cerebrovasc Dis 18:232-8. 2009..The objective of this study was to determine the impact of the new Accreditation Council for Graduate Medical Education (ACGME) duty hour regulations on AIS outcomes including inhospital mortality...
- Acute stroke therapy: beyond i.v. tPAAnthony J Furlan
Cerebrovascular Center, Department of Neurology, The Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 69:730-4. 2002..Several medical centers are turning to angiography to guide intra-arterial infusion of thrombolytic agents and mechanical endovascular interventions...
- Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic strokeAnthony J Furlan
Department of Neurology, University of Massachusetts Medical School, Worcester, Mass 01605 2982, USA
Stroke 36:398-9. 2005
- Ethics consultations in stroke and neurological disease: a 7-year retrospective reviewAdrienne R Boissy
Neurological Institute, Cleveland Clinic Foundation, Mellen Center for Multiple Sclerosis, U 10, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Neurocrit Care 9:394-9. 2008..To describe the reasons for and methods of resolution of ethics consultations conducted in neurological and neurointensive care units affiliated with a single health care facility...
- Patent foramen ovale and stroke: to close or not to close?Anthony J Furlan
Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA
Cleve Clin J Med 74:S118-20. 2007